Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Int J Clin Pharmacol Biopharm1
Search Results
Sort by
- BookSheldon Krimsky.Summary: Employing a series of Socratic dialogues, this study of the use of stem cells in medicine and medical research examines the ethical and public policy issues that confront scientists, clinicians, and the public health community.
Contents:
Harnessing stem cells for regenerative medicine
Hope
Why is this cell different from other cells?
The president's stem cells
The Dickey-Wicker enigma
The moral status of embryos
Creating good from immoral acts
Circumventing embryocide
My personalized beta cells for diabetes
Repairing brain cells in stroke victims
Reversing macular degeneration
My stem cells, my cancer
Reprogramming cells
My personalized disease cells
To clone or not to clone : that is the question
Patenting human embryonic stem cells is immoral and illegal (in Europe)
My embryo is auctioned on the internet
Here comes the egg man : oocytes & embryos.org
Human-animal chimeras and hybrids
Stem cell tourism
Social media meets science hype
Feminism and the commercialization of human eggs/embryos
Was my birth embryo me?
Embryos without ovaries
How my cells became drugs
A clinical trial for paralysis treatment.Digital Access eBook Comp Acad 2015 - ArticleVinazzer H.Int J Clin Pharmacol Biopharm. 1977 May;15(5):214-6.In a double blind study on 20 anticoagulated patients, the influence of the anti-inflammatory drug 1-isopropyl-4-phenyl-7-methyl-2 (1H) quinazolone on the degree of hypocoagulability was examined. In comparison to a placebo group, there was no statistical difference in the Quick precentage, in coagulation factors II, VII, and X, and in platelet aggregation induced by collagen and by epinephrine respectively. In addition, no increased bleeding tendency could be observed during the study.